(Q40188550)

reason for preferred rank

18 September 2017

Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial (English)

1 reference

10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2149::AID-CNCR2820420510%3E3.0.CO;2-5

13 January 2023

Chemotherapy studies in primary liver cancer: a prospective randomized clinical trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A214218

13 January 2023

1 reference

1 reference

1 reference

10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2149::AID-CNCR2820420510%3E3.0.CO;2-5

13 January 2023

author name string

G. Falkson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A214218

13 January 2023

C. G. Moertel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A214218

13 January 2023

P. Lavin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A214218

13 January 2023

F. J. Pretorius

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A214218

13 January 2023

P. P. Carbone

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A214218

13 January 2023

language of work or name

English

0 references

publication date

1 November 1978

1 reference

full work available at URL

18 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197811)42:5%3C2149::AID-CNCR2820420510%3E3.0.CO;2-5

1 reference

10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2149::AID-CNCR2820420510%3E3.0.CO;2-5

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197811)42:5%3C2149::AID-CNCR2820420510%3E3.0.CO;2-5

13 January 2023

1 reference

10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2149::AID-CNCR2820420510%3E3.0.CO;2-5

13 January 2023

1 reference

18 September 2017

42

1 reference

18 September 2017

2149-2156

1 reference

18 September 2017

5

1 reference

Proceedings: Primary liver cancer. A review of the clinical features, blood groups, serum enzymes, therapy, and survival of 65 cases

18 September 2017

1

1 reference

10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2149::AID-CNCR2820420510%3E3.0.CO;2-5

Adenocarcinomas of stomach, pancreas, liver, and biliary tracts. Survival of 328 patients treated with fluoropyrimidine therapy.

13 January 2023

2

1 reference

10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2149::AID-CNCR2820420510%3E3.0.CO;2-5

Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinoside

13 January 2023

4

1 reference

10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2149::AID-CNCR2820420510%3E3.0.CO;2-5

Malignant hepatoma in the Bantu

13 January 2023

5

1 reference

10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2149::AID-CNCR2820420510%3E3.0.CO;2-5

A double-blind comparison of intensive course 5-fluorouracil by oral vs. intravenous route in the treatment of colorectal carcinoma

13 January 2023

6

1 reference

10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2149::AID-CNCR2820420510%3E3.0.CO;2-5

Treatment of cancer with weekly intravenous 5-fluorouracil

13 January 2023

8

1 reference

10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2149::AID-CNCR2820420510%3E3.0.CO;2-5

Oral fluorouracil therapy of hepatoma

13 January 2023

9

1 reference

10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2149::AID-CNCR2820420510%3E3.0.CO;2-5

5-Fluorouracil in hepatocellular carcinoma.Report of twenty-one cases

13 January 2023

11

1 reference

10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2149::AID-CNCR2820420510%3E3.0.CO;2-5

13 January 2023

Cancer Treatment Reports

14

60

729

Moertel

1976

1 reference

10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2149::AID-CNCR2820420510%3E3.0.CO;2-5

Clinical management of advanced gastrointestinal cancer

13 January 2023

15

1 reference

10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2149::AID-CNCR2820420510%3E3.0.CO;2-5

Treatment of hepatocellular carcinoma with adriamycin.Preliminary communication

13 January 2023

16

1 reference

10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2149::AID-CNCR2820420510%3E3.0.CO;2-5

A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States

13 January 2023

18

1 reference

10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2149::AID-CNCR2820420510%3E3.0.CO;2-5

13 January 2023

Identifiers

10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5

1 reference

18 September 2017

1 reference